Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017 (PROGRESS)

Civil Hospices of Lyon

Status: Unknown

Conditions: Lung Diseases, Interstitial; Lung Disease With Systemic Sclerosis

Treatments: Other: epidemiology, healthcare costs in non-IPF PF-ILD and SSc-ILD

Study type: Observational

Funder types: Other

Identifiers

NCT03858842

69HCL19_0027

Details and patient eligibility

About

Interstitial lung diseases (ILDs) are a heterogeneous group of disorders, which encompass a wide range of conditions. In some patients with fibrosing ILDs, a progressive phenotype similar to that observed in idiopathic pulmonary fibrosis (IPF) may develop during the course of the disease (PF-ILD), including patients with systemic sclerosis (SSc)-related ILD.

The aim of the study is to estimate the incidence and prevalence and to describe the characteristics of patients diagnosed with non-IPF PF-ILD and SSc-ILD, to describe the natural course of disease, and to explore the correlation between mortality and Forced Vital Capacity (FVC) of the patients with non-IPF PF-ILD.

This study will be based on two data sources: the French national medico administrative database (SNDS) and the ILD cohort from the National French center for rare pulmonary diseases in Lyon, France.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients hospitalized for PF-ILD and SSc-ILD in France between 01/01/2010 and 31/12/2017
• Men or women aged ≥ 18 years old at diagnosis

Exclusion criteria

• Patients treated by anti-fibrotic
• Patients diagnosed with IPF

Trial design

100 participants in 1 patient group

PF-ILD and SSc-ILD patients

Description:

PF-ILD and SSc-ILD patients

Treatment:

Other: epidemiology, healthcare costs in non-IPF PF-ILD and SSc-ILD